Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen G Ross

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Plos One|November 23, 2020
Social Enterprise Model (SEM) for private sector tuberculosis screening and care in BangladeshSayera Banu, Farhana Haque, Shahriar Ahmed, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2020
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illnessSabeena Ahmed, Mohammad Mahbubul Karim, Allen G Ross, et al.
Gut Pathogens|April 12, 2023
Vibrio cholerae O1 associated with recent endemic cholera shows temporal changes in serotype, genotype, and drug-resistance patterns in BangladeshFatema Tuz Jubyda, Kazi Sumaita Nahar, Indrajeet Barman, et al.
Journal of Global Health|January 17, 2025
Population attributable fractions for modifiable risk factors of neonatal, infant, and under-five mortality in 48 low- and middle-income countriesKedir Y Ahmed, Subash Thapa, Getiye D Kibret, et al.
Lancet (London, England)|December 10, 2022
Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trialKhaelqu Zaman, Ananda S Bandyopadhyay, Masuma Hoque, et al.
JAMA Network Open|October 18, 2023
Population-Modifiable Risk Factors Associated With Childhood Stunting in Sub-Saharan AfricaKedir Y Ahmed, Abel F Dadi, Felix Akpojene Ogbo, et al.
International Journal for Parasitology|June 15, 2014
A multi-component integrated approach for the elimination of schistosomiasis in the People's Republic of China: design and baseline results of a 4-year cluster-randomised intervention trialDarren J Gray, Yue-Sheng Li, Gail M Williams, et al.
Eclinicalmedicine|February 9, 2024
Population modifiable risk factors associated with under-5 acute respiratory tract infections and diarrhoea in 25 countries in sub-Saharan Africa (2014-2021): an analysis of data from demographic and health surveysKedir Y Ahmed, Abel F Dadi, Getiye Dejenu Kibret, et al.
Plos Neglected Tropical Diseases|November 21, 2012
A novel procedure for precise quantification of Schistosoma japonicum eggs in bovine fecesBin Xu, Catherine A Gordon, Wei Hu, et al.
Vaccine|July 5, 2021
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in BangladeshFahima Chowdhury, Khalid Ali Syed, Afroza Akter, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Plos One|November 23, 2020
Social Enterprise Model (SEM) for private sector tuberculosis screening and care in BangladeshSayera Banu, Farhana Haque, Shahriar Ahmed, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2020
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illnessSabeena Ahmed, Mohammad Mahbubul Karim, Allen G Ross, et al.
Gut Pathogens|April 12, 2023
Vibrio cholerae O1 associated with recent endemic cholera shows temporal changes in serotype, genotype, and drug-resistance patterns in BangladeshFatema Tuz Jubyda, Kazi Sumaita Nahar, Indrajeet Barman, et al.
Journal of Global Health|January 17, 2025
Population attributable fractions for modifiable risk factors of neonatal, infant, and under-five mortality in 48 low- and middle-income countriesKedir Y Ahmed, Subash Thapa, Getiye D Kibret, et al.
Lancet (London, England)|December 10, 2022
Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trialKhaelqu Zaman, Ananda S Bandyopadhyay, Masuma Hoque, et al.
JAMA Network Open|October 18, 2023
Population-Modifiable Risk Factors Associated With Childhood Stunting in Sub-Saharan AfricaKedir Y Ahmed, Abel F Dadi, Felix Akpojene Ogbo, et al.
International Journal for Parasitology|June 15, 2014
A multi-component integrated approach for the elimination of schistosomiasis in the People's Republic of China: design and baseline results of a 4-year cluster-randomised intervention trialDarren J Gray, Yue-Sheng Li, Gail M Williams, et al.
Eclinicalmedicine|February 9, 2024
Population modifiable risk factors associated with under-5 acute respiratory tract infections and diarrhoea in 25 countries in sub-Saharan Africa (2014-2021): an analysis of data from demographic and health surveysKedir Y Ahmed, Abel F Dadi, Getiye Dejenu Kibret, et al.
Plos Neglected Tropical Diseases|November 21, 2012
A novel procedure for precise quantification of Schistosoma japonicum eggs in bovine fecesBin Xu, Catherine A Gordon, Wei Hu, et al.
Vaccine|July 5, 2021
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in BangladeshFahima Chowdhury, Khalid Ali Syed, Afroza Akter, et al.
Pageof 13